We are live on
!
Find out more
AP
Andera Partners Portfolio holdings
AUM
$177M
This Fund
S&P 500
This Quarter
Est. Return
-7.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
+$309K
(+0.17%)
Cap. Flow
+$27.7M
Cap. Flow
% of AUM
15.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGMB
AgomAb Therapeutics NV
AGMB
|
+$21.8M |
| 2 |
KMTS
Kestra Medical Technologies
KMTS
|
+$3.66M |
| 3 |
NYXH
Nyxoah
NYXH
|
+$2.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CTC
AGC
CPL
ACM
WFL
PFP
ES
ACM
Andera Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Andera Partners held 7 positions worth $177M, up 0.17% from $177M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Andera Partners deployed $27.7M of net new capital in Q1 2026, opening 2 new positions and adding to 1 existing holding. Its largest new stake was AgomAb Therapeutics NV: 1,538,702 shares worth $16.1M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Andera Partners's largest Q1 2026 buy was AgomAb Therapeutics NV: 1,538,702 shares worth $16.1M.
- Andera Partners added most to Kestra Medical Technologies in Q1 2026, an estimated $3.66M increase.
- Andera Partners's ten largest holdings make up 100% of its $177M portfolio in Q1 2026.
- Andera Partners opened 2 new positions and closed 0 in Q1 2026.
- Andera Partners's portfolio value rose 0.17% quarter-over-quarter to $177M.
Based on Andera Partners's 13F filing for Q1 2026, filed 11 May 2026.